Reg(G), led by Abhishek Singh, emerged as the undisputed leader, delivering a solid 18.10% return in the last year ...

The alternative investment arm of Motilal Oswal Financial Services Ltd has acquired a majority stake in export-focused bulk ...

Motilal Oswal Alternates invests Rs 460 crore for a majority stake in Mega Fine Pharma, an export-focused integrated API ...

Motilal Oswal Alternate Investment Advisors, a subsidiary of MO Financial Services, is investing up to Rs 460 crore for a majority stake in Megafine P.

Investors with very high risk appetite should invest in the Motilal Oswal Active Momentum Fund for 5 to 7 years.

Motilal Oswal Alternates announced a Rs 450-crore investment in Mega Fine Pharma for a majority stake. The Sanghvi family also increased their stake. The investment aims to transform the API-focused ...

Motilal Oswal Alternates announced a Rs 460-crore investment for a majority stake in Mega Fine Pharma. The Sanghvi family also increased their stakes. The company produces niche active pharmaceutical ...

Megafine currently operates two USFDA-approved manufacturing facilities located in Nashik, Maharashtra, and Vapi, Gujarat, ...

MO Alternate Investment Advisors, a subsidiary of Motilal Oswal Financial Services, is investing up to Rs 460 crore for a majority stake in Megafine Pharma. The Sanghvi family, one of the founding ...

The Motilal Oswal Alternatives and Accion-backed NBFC recently amended its Memorandum and Articles of Association to increase ...

Execution remains key, say analysts as Federal Bank targets to move up several notches from its current no. 9 spot to among ...

While its India business clocked steady 2% revenue growth in the December quarter, revenue from Europe fell as much as 22%.